Smartleaf Asset Management LLC Acadia Pharmaceuticals Inc Transaction History
Smartleaf Asset Management LLC
- $981 Billion
- Q4 2024
A detailed history of Smartleaf Asset Management LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 859 shares of ACAD stock, worth $16,217. This represents 0.0% of its overall portfolio holdings.
Number of Shares
859
Previous 284
202.46%
Holding current value
$16,217
Previous $4.46 Million
221.8%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ACAD
# of Institutions
290Shares Held
158MCall Options Held
901KPut Options Held
314K-
Baker Bros. Advisors LP New York, NY42.9MShares$810 Million7.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.8MShares$261 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY13.7MShares$259 Million3.36% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$228 Million0.0% of portfolio
-
State Street Corp Boston, MA5.97MShares$113 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.06B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...